Intravenous drip. Source: Getty Images Neoadjuvant dd-MVAC improved 5-year overall survival when compared to gemcitabine and cisplatin in a phase 3 trial of patients with MIBC. Dose-dense methotrexate ...
Renal and Urology News, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results